QUEST Diagnostics has agreed to
develop a blood based colon cancer
testing service using Australian life
sciences company, Clinical
Genomics, gene markers.
Quest is one of the world’s leading
diagnostic testing companies, and
will use Clinical Genomics’ genebased
biomarkers to develop a new
generation of tests to help aid
colon cancer detection in the US.
The research on which the Clinical
Genomics’ markers are based is the
result of over five years of scientific
collaboration between Clinical
Genomics, CSIRO and the Flinders
Centre for Innovation in Cancer at
Flinders University in Australia.The above article was sent to subscribers in Pharmacy Daily's issue from 05 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Nov 12
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.